CBIO Catalyst Biosciences Inc.

9.62
-0.25  -3%
Previous Close 9.87
Open 9.77
Price To Book 0.88
Market Cap 114889053
Shares 11,942,729
Volume 100,603
Short Ratio
Av. Daily Volume 177,026

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181154638
  2. 8-K - Current report 181153741
  3. 8-K - Current report 181050270
  4. 8-K - Current report 181021808
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 18989289

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Cohort 6 patients (2) safety concerns - presence of neutralizing antibodies - noted June 18, 2018. Additional data due December 2018.
CB 2679d/ ISU304
Hemophilia B
Phase 2 final data due 1H 2019.
Marzeptacog alfa
Hemophilia